Ironwood Pharmaceuticals, Inc. · NASDAQ:IRWD
The Vanguard Group reported a 9.80% stake in Ironwood Pharmaceuticals, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed Apr 30, 2025
The Vanguard Group reported a 9.80% stake in Ironwood Pharmaceuticals, Inc., 15,696,161 shares, as a passive investor on Mar 31, 2025. Filed Apr 30, 2025 (Schedule 13G/A).
- Stake
- 9.80%
- Shares
- 15,696,161
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 9.80% | 15,696,161 |
Source
Related
- Ironwood Pharmaceuticals, Inc.
- The Vanguard Group
- Ironwood Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · The Vanguard Group · Jul 7, 2025
- Schedule 13G/A · The Vanguard Group · Jan 31, 2025
- Form 4 · Denner Alexander J · Sep 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Silber Jeffrey · Jul 22, 2026